Cargando…

Immediate versus deferred stenting for patients undergoing primary or emergent percutaneous coronary intervention: Protocol for a systematic review and meta-analysis

INTRODUCTION: Primary or emergent percutaneous coronary intervention (PCI) with stenting is the standard treatment for patients with ST-segment elevation myocardial infarction (STEMI) or non-STEMI acute coronary syndromes (ACS) at high risk. The value of delayed stenting following balloon-facilitate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yong, Islam, Sheikh Mohammed Shariful, Chow, Clara K., Chen, Shiqun, Siddiqui, Muhammad Umer, Li, Qiang, Lin, Kai-yang, Wang, Kun, Sun, Guoli, Zhou, Ying-ling, Chen, Jiyan, Brieger, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	3400
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708921/ https://www.ncbi.nlm.nih.gov/pubmed/29381922 http://dx.doi.org/10.1097/MD.0000000000008477

Ejemplares similares

Effects of deferred versus immediate stenting on left ventricular function in patients with ST elevation myocardial infarction
por: Kook, Hyungdon, et al.
Publicado: (2021)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Relationship Between the Urine Flow Rate and Risk of Contrast-Induced Nephropathy After Emergent Percutaneous Coronary Intervention
por: Liu, Yong, et al.
Publicado: (2015)

Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Tunçez, Abdullah, et al.
Publicado: (2017)

An analysis of factors related to the development of in-stent restenosis after percutaneous coronary intervention
por: Zhang, Gai, et al.
Publicado: (2020)

Effects of intravenous hydration on risk of contrast induced nephropathy and in-hospital mortality in STEMI patients undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials
por: Liu, Yong, et al.
Publicado: (2019)

Successful percutaneous stent implantation for isolated dismal transverse aortic arch kinking
por: Zuo, Zhi-Liang, et al.
Publicado: (2017)

Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions – is there an association?
por: Stipinovic, Mario, et al.
Publicado: (2019)

Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhu, Kun, et al.
Publicado: (2020)

Percutaneous mechanical circulatory support devices in high-risk patients undergoing percutaneous coronary intervention: A meta-analysis of randomized trials
por: Shi, Wenhai, et al.
Publicado: (2019)

Treatment effect of metformin combined with atorvastatin in reducing in-stent restenosis after percutaneous coronary intervention in coronary artery disease patients with type 2 diabetic patients
por: Chen, Mingli, et al.
Publicado: (2022)

The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study
por: Ma, Huan, et al.
Publicado: (2017)

A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Li, Yachao, et al.
Publicado: (2023)

The effectiveness of Salvianolate injection for in-stent restenosis after percutaneous coronary intervention: A protocol for systematic review and meta-analysis
por: Zhang, Miao, et al.
Publicado: (2022)

Efficacy and safety of dual antiplatelet therapy after percutaneous coronary drug-eluting stenting: A network meta-analysis
por: Luo, Lin, et al.
Publicado: (2022)

Clinical outcomes of patients with multivessel coronary artery disease treated with robot-assisted coronary artery bypass graft surgery versus one-stage percutaneous coronary intervention using drug-eluting stents
por: Su, Chieh-Shou, et al.
Publicado: (2019)

Effect of drug-eluting stents on 1-year risk of new-onset atrial fibrillation in patients with acute myocardial infarction treated with percutaneous coronary intervention
por: Yu, Fa-Chang, et al.
Publicado: (2020)

Effect of glomerular filtration rate in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis
por: Zhu, Xiang, et al.
Publicado: (2022)

Beneficial effects of high-density lipoprotein (HDL) on stent biocompatibility and the potential value of HDL infusion therapy following percutaneous coronary intervention
por: Liu, Jian-Di, et al.
Publicado: (2022)

Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant)
por: Zheng, Wen, et al.
Publicado: (2020)

Outcomes of off- and on-hours admission in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A retrospective observational cohort study
por: Geng, Jin, et al.
Publicado: (2016)

Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: A Cohort study
por: Zhang, Wutang, et al.
Publicado: (2020)

Efficacy of Adenosine in Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: A PRISMA-Compliant Meta-Analysis
por: Gao, Qijun, et al.
Publicado: (2015)

Effect of Beta Blockers and Renin–Angiotensin System Inhibitors on Survival in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Lee, Pil Hyung, et al.
Publicado: (2016)

The triglyceride-glucose index and contrast-induced nephropathy in non-ST elevation myocardial infarction patients undergoing percutaneous coronary intervention
por: Gursoy, Erol, et al.
Publicado: (2023)

Predictive performance of aortic arch calcification for clinical outcomes in patients with acute coronary syndrome that undergo percutaneous coronary intervention: A prospective clinical study
por: Ma, Xiaoteng, et al.
Publicado: (2019)

Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
por: Liu, Xiao-Qiang, et al.
Publicado: (2020)

Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study
por: Hu, Yue-cheng, et al.
Publicado: (2021)

Charlson comorbidity index and 1-year poor outcomes in elderly patients undergoing successful percutaneous coronary intervention: A retrospective study
por: Balun, Ahmet, et al.
Publicado: (2023)

Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: An Observational Study
por: Yeh, Yen-Ting, et al.
Publicado: (2016)

Cardiovascular outcomes associated with Ultrathin bioresorbable polymer sirolimus eluting stents versus thin, durable polymer everolimus eluting stents following percutaneous coronary intervention in patients with type 2 diabetes mellitus: A meta-analysis of published studies
por: Deng, Shibing, et al.
Publicado: (2020)

Prognostic value of CHADS(2) and CHA(2)DS(2)-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Ma, Xiaoteng, et al.
Publicado: (2020)

Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study
por: Zhang, Juan, et al.
Publicado: (2022)

High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in East Asian patients undergoing percutaneous coronary intervention: A meta-analysis of fifteen randomized controlled trials
por: Liu, Jiahui, et al.
Publicado: (2021)

Effects of recombinant human brain natriuretic peptide in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A systematic review and meta-analysis
por: Ning, Cheng, et al.
Publicado: (2020)

The efficacy and safety of Shenfu injection in patients undergoing percutaneous coronary intervention for ST segment elevation myocardial infarction: A protocol for systematic review and meta-analysis
por: Yan, Xiafeng, et al.
Publicado: (2023)

Influence of hypercholesterolemia and diabetes on long-term outcome in patients with stable coronary artery disease receiving percutaneous coronary intervention
por: Lin, Mao-Jen, et al.
Publicado: (2019)

Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease: A systematic review and meta-analysis
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)

Impact of Chronic Total Occlusion in a Noninfarct-related Artery on Clinical Outcomes in Patients With Acute ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Zhang, Hui-Ping, et al.
Publicado: (2016)

Myocardial protective effect of intracoronary administration of nicorandil and alprostadil via targeted perfusion microcatheter in patients undergoing elective percutaneous coronary intervention: A randomized controlled trial
por: Zhang, Weifeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_88t5ui12k68ujbthvetvl4k5gf